79066961 - ARK THERAPEUTICS

Information

  • Trademark
  • 79066961
  • Serial Number
    79066961
  • Registration Number
    3742666
  • Filing Date
    March 13, 2009
    15 years ago
  • Registration Date
    January 26, 2010
    14 years ago
  • Transaction Date
    October 12, 2019
    5 years ago
  • Status Date
    March 13, 2019
    5 years ago
  • Published for Opposition Date
    November 10, 2009
    15 years ago
  • Location Date
    January 26, 2010
    14 years ago
  • Status Code
    404
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    WIENER, MICHAEL A
  • Attorney Name
    CYNTHIA C. WEBER
    Law Office Assigned Location Code
    L80
  • Owners
Mark Drawing Code
3000
Mark Identification
ARK THERAPEUTICS
Case File Statements
  • CC0000: The color(s) blue and yellow is/are claimed as a feature of the mark.
  • D10000: "THERAPEUTICS"
  • DM0000: The mark consists of an outer arc in the color blue and a concentric inner arc in the color yellow. To the right of the arcs appears the term "ARK" in the color blue over the term "THERAPEUTICS" also in blue.
  • GS0011: Diagnostic protein preparations for use in science, scientific diagnostics and industry; diagnostic preparations of genes for use in science, scientific diagnostics and industry
  • GS0051: Pharmaceutical preparations for the treatment of wounds, burns, vascular and circulatory system related diseases, cancer, malignant glioma and other malignant brain tumours, macular degeneration, lipodystrophy and other metabolic conditions associated with the use of anti-HIV therapy, cachexia and muscle wasting; pharmaceutical preparations for the prevention of stenosis, namely, stenosis caused by intimal hyperplasia following surgical procedures; pharmaceutical preparations to promote or suppress angiogenesis and enhance blood flow; pharmaceutical preparations for increasing the efficiency of muscle cell energy production; therapeutic agents for the treatment of wounds, burns, vascular and circulatory system related diseases, cancer, malignant glioma and other malignant brain tumours, macular degeneration, lipodystrophy and other metabolic conditions associated with the use of anti-HIV therapy, cachexia and muscle wasting; therapeutic agents for the prevention of stenosis, namely, stenosis caused by intimal hyperplasia following surgical procedures; therapeutic agents to promote or suppress angiogenesis and enhance blood flow; therapeutic agents for increasing the efficiency of muscle cell energy production; diagnostic preparations for medical purposes; protein preparations for clinical or medical laboratory use, namely for targeting therapeutic agents to specific sites; medical dressings; surgical dressings; burn dressings; wound dressings; absorbent wound and burn dressings in the nature of pads; foot and hand dressings for medical purposes; fluid handling foot and hand dressings for medical purposes; preparations of genes for therapeutics purposes namely for the treatment of wounds, burns, vascular and circulatory system related diseases, cancer, malignant glioma and other malignant brain tumours, macular degeneration, lipodystrophy and other metabolic conditions associated with the use of anti-HIV therapy, cachexia and muscle wasting; preparations of genes for therapeutic purposes namely for the prevention of stenosis, namely, stenosis caused by intimal hyperplasia following surgical procedures; preparations of genes for therapeutic purposes namely to promote or suppress angiogenesis and enhance blood flow; preparations of genes for therapeutic purposes namely for increasing the efficiency of muscle cell energy production
  • GS0101: Boots and gloves for orthopaedic and medical purposes; boots and gloves for medical purposes with the ability to handle wound fluid; boots and gloves for medical use and absorbent filters, liners and inserts for use therewith; filters, soles and absorbent inserts for socks, boots and gloves for medical purposes, namely, for the treatment of wounds and burns; foot and hand dressings for medical purposes, namely, for the treatment of wounds and burns; parts and fittings for all the aforesaid goods
  • GS0421: Scientific, medical and clinical research, all in the field of the treatment of wounds, burns, vascular and circulatory system related diseases, cancer, malignant glioma and other malignant brain tumours, macular degeneration, lipodystrophy and other metabolic conditions associated with the use of anti-HIV therapy, cachexia and muscle wasting, prevention of stenosis, increasing the efficiency of muscle cell energy production and promoting or suppressing angiogenesis and enhancing blood flow; scientific, medical and clinical research for the discovery, design, creation, development and testing in the field of pharmaceutical preparations and therapeutically active substances; scientific, medical and clinical research in the field of gene therapy; scientific, medical and clinical research for the discovery, design, creation, development and testing in the field of pharmaceutical preparations and therapeutically active substances for use in the field of gene therapy; advisory services relating to the aforesaid services; scientific, medical and clinical research in the field of genes and genetics; medical and scientific research, namely, conducting gene therapy trials; provision of information relating to the above
Case File Event Statements
  • 10/11/2019 - 5 years ago
    30 - NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED Type: DENC
  • 10/11/2019 - 5 years ago
    29 - DEATH OF INTERNATIONAL REGISTRATION Type: DETH
  • 6/16/2017 - 7 years ago
    28 - TOTAL INVALIDATION PROCESSED BY THE IB Type: INNT
  • 5/11/2017 - 7 years ago
    27 - TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB Type: INTS
  • 5/11/2017 - 7 years ago
    26 - INVALIDATION PROCESSED Type: INPC
  • 5/2/2017 - 7 years ago
    25 - TOTAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INTR
  • 9/2/2016 - 8 years ago
    24 - CANCELLED SECTION 71 Type: C71T
  • 2/7/2013 - 11 years ago
    23 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 5/24/2010 - 14 years ago
    22 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 5/24/2010 - 14 years ago
    21 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 4/26/2010 - 14 years ago
    20 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 1/26/2010 - 14 years ago
    19 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 11/10/2009 - 15 years ago
    18 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 10/21/2009 - 15 years ago
    17 - NOTICE OF PUBLICATION Type: NPUB
  • 10/7/2009 - 15 years ago
    16 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 10/5/2009 - 15 years ago
    15 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 9/12/2009 - 15 years ago
    14 - AMENDMENT FROM APPLICANT ENTERED Type: ACEC
  • 9/12/2009 - 15 years ago
    13 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 9/12/2009 - 15 years ago
    12 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 9/12/2009 - 15 years ago
    11 - ASSIGNED TO LIE Type: ALIE
  • 9/9/2009 - 15 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 7/18/2009 - 15 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 6/10/2009 - 15 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 6/10/2009 - 15 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 6/10/2009 - 15 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 6/9/2009 - 15 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 6/5/2009 - 15 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 4/28/2009 - 15 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 4/24/2009 - 15 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 4/23/2009 - 15 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR